NSE: TORNTPHARM
TORRENT PHARMACEUTICALS L
Price history
+8.60% over 3M
Performance
52-week range
Position in day range
TORNTPHARM stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹4,947.9
RSI (14)
55
Neutral momentum
Volatility (ATR)
2.04%
Moderate
Close streak
2d up
Volume vs 20d avg
0.93x
From 52W high
-5.42%
Up from 52W low
+42.66%
Green days (20)
11/20
Monthly seasonality
Average monthly move for TORNTPHARM across the available price history.
Key statistics
Open
4,929
Day high
4,988
Day low
4,894
Prev close
4,965.5
Volume
2.63 L
Avg vol (20d)
2.83 L
52W high
5,250
52W low
3,480.6
TORNTPHARM quarterly results
All TORNTPHARM results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹4,835 cr
+54.6% YoY
Net profit
₹566 cr
+3.3% YoY
Operating profit
₹1,071 cr
+28.9% YoY
EPS
₹14.87
-8.2% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹4,835 cr | ₹1,071 cr | ₹566 cr | 22.2% | 11.7% | ₹14.87 | +3.3% | +45.5% |
| Q4 FY262026-03-31 | ₹4,128 cr | ₹848 cr | ₹389 cr | 20.5% | 9.4% | ₹11.51 | — | -38.7% |
| Q3 FY262025-12-31 | ₹3,251 cr | ₹882 cr | ₹635 cr | 27.1% | 19.5% | ₹18.77 | — | +7.4% |
| Q2 FY262025-09-30 | ₹3,246 cr | ₹879 cr | ₹591 cr | 27.1% | 18.2% | ₹17.45 | — | +7.8% |
| Q1 FY262025-06-30 | ₹3,128 cr | ₹831 cr | ₹548 cr | 26.6% | 17.5% | ₹16.19 | — | — |
| TTM (last 4 quarters) | ₹15,460 cr | ₹3,680 cr | ₹2,181 cr | 23.8% | 14.1% | ₹62.60 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
No stories tagged with TORNTPHARM yet — see the latest from the markets desk below.
Latest market news
Jubilant Pharmova Share Price Trades Flat at ₹1,025.20 Today — Volumes, 52-Week Range and What to Watch Next
Jubilant Pharmova (JUBLPHARMA) trades at ₹1,025.20, -0.45 (-0.04%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Coforge Share Price Opens Gap-Down at ₹1,807.30: What Is Driving COFORGE Today, and the Levels That Matter
Coforge (COFORGE) trades at ₹1,846.50, +13.40 (+0.73%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Aavas Financiers Share Price Edges Lower to ₹1,271.50 Today — Volumes, 52-Week Range and What to Watch Next
Aavas Financiers (AAVAS) trades at ₹1,271.50, -14.60 (-1.15%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Morning Market Buzz, 12 September 2026: IPOs Tops the Coverage Ahead of Policy And Macro Data and Banks And NBFCs
The most-covered market themes in the morning session on 12 September 2026 — IPOs, policy and macro data, banks and NBFCs — with our live numbers for each and links to the publishers running the story.
Raymond Share Price Hits 52-Week High, Up 14.85%: What Is Driving RAYMOND Today, and the Levels That Matter
Raymond (RAYMOND) trades at ₹1,002.80, +148.95 (+14.85%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
HDFC AMC Edges Lower to ₹2,403.90 — Should Investors Read This as a Trend or a One-Day Move?
HDFC AMC (HDFCAMC) trades at ₹2,403.90, -29.90 (-1.24%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.